Press Releases Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
2.01 ^USD	-1.95%		+12.29%	-79.51%

Jun. 03	Jefferies & Co Initiates Coverage on Pacific Biosciences of California With Buy Rating, $4 Price Target	MT
May. 15	Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	May. 15	PR
Pacific Biosciences of California : PacBio Q1 2024 Earnings Presentation	May. 09	PU
Pacific Biosciences: Q1 Earnings Snapshot	May. 09	AQ
PacBio Announces First Quarter 2024 Financial Results	May. 09	PR
NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries	May. 01	AQ
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance	Apr. 16	PR
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	Mar. 27	PR
PacBio Grants Equity Incentive Award to New Employee	Mar. 22	PR
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions	Mar. 12	PR
PacBio to Present at Upcoming Investor Conferences	Feb. 26	PR
Federal Circuit Affirms Claim Construction And How It Applies	Feb. 20	AQ
Pacific Biosciences: Q4 Earnings Snapshot	Feb. 15	AQ
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results	Feb. 15	PR
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch	Feb. 13	PR
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	Feb. 05	PR
PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024	Jan. 25	PR
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions	Jan. 15	PR
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively	Jan. 08	PR
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference	Dec. 27	PR
PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors	Dec. 11	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Press Releases

Filters